This activation subsequently triggers the PYK2/c-Src signaling pathway, which independently activates the ERK signaling cascade through a Raf/MEK-independent mechanism, ultimately modulating tumor cell invasion and metastatic potential. Here, PTK2B is linked to neoplasm.